Completed OBSERVATIONAL NCT05300412

The Role of Interleukin-7 Serum Level as Biological Marker in Breast Cancer

The Role of Interleukin-7 Serum Level as Biological Marker in Breast Cancer: a Cross-sectional, Observational, and Analytical Study

Sponsor: University Clinical Centre of Kosova

Conditions Breast Cancer Invasive

Updated 3 times since 2022 Last updated: Mar 18, 2022 Started: Jun 5, 2018 Primary completion: Sep 10, 2019 Completion: Dec 20, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Breast Cancer Invasive and is currently completed. University Clinical Centre of Kosova leads this study, which shows 3 recorded versions since 2018 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Apr 2022 — Jul 2024 [monthly]

Completed

First recorded

Jun 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Clinical Centre of Kosova

Data source: University Clinical Centre of Kosova

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pristina, Kosovo